Skip to content
Research Article Open access CC BY 4.0

COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome)

Mehmet Unal, Tulay Irez

Asian Journal of Medicine and Health · pp. 1–11 · Published 18 May 2020

10.9734/ajmah/2020/v18i430194

Abstract

Coronaviruses (CoV) are a large group from the Coronaviridae family that cause a variety of diseases, from the common cold to more serious clinical conditions such as SARS-CoV and MERS-CoV. This pathogen, which has a single chain, positive polarity and enveloped RNA viruses and causes bilateral interstitial pneumonia, has been associated by the World Health Organization (WHO) as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The resulting disease was defined as COVID-19. SARS-CoV-2 belongs to the family of β-coronavirus. Studies have reported that SARS-CoV-2 uses membrane-bound ACE2 to access target cells. It is understood that the virus is transmitted from bats to people, from person to person by droplet or by the contact of the sick person with respiratory secretion materials into the mouth, nose and eye mucous membranes of healthy people. The most common clinical findings were fever (87.9%), cough (67.7%), and weakness (38.1%). The exact diagnosis of Covid-19 is based on virus isolation or RT-PCR positivity. The sensitivity of Thorax CT in the diagnosis of Covid-19 is 97%. Most of the treatments applied are symptomatic. Remdesivir, Chloroquine, Arbidol, Kaletra, lopinavir / ritonavir and remdesivir have been proposed as antiviral agents that can be used in Covid-19 therapy. In order to be protected, attention should be paid to social distance, personal hygiene, a healthy lifestyle, a good sleep pattern, regular exercise, adequate and balanced nutrition. Although the outbreak started in China, it is also quite common in Europe and America. As of May 2, 2020, case reports were made from 215 countries. It has been declared as a pandemic by WHO because of its high transmission rate. The situation is of great importance for global public health. In this paper, we have systematically reviewed the SARS-CoV-2 and this report aims to give information about the genetic structure, pathogenic feature, source of infection, routes of transmission, etiopathogenesis, clinical features, diagnosis, treatment and prevention of the virus and to be a reference for future research, measures and treatments. This review aims to investigate the most current trend of COVID-19.

SARS-Cov-2 COVID-19 coronavirus severe acute respiratory syndrome

References (59)

  1. 1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [DOI]
  2. 2 Clinical Characteristics of Coronavirus Disease 2019 in China [DOI]
  3. 3 A Novel Coronavirus from Patients with Pneumonia in China, 2019 [DOI]
  4. 4 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor [DOI]
  5. 5 Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia [DOI]
  6. 6 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [DOI]
  7. 7 An interactive web-based dashboard to track COVID-19 in real time [DOI]
  8. 8 Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation [DOI]
  9. 9 Pathological findings of COVID-19 associated with acute respiratory distress syndrome [DOI]
  10. 10 A novel coronavirus outbreak of global health concern [DOI]
  11. 11 World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) [DOI]
  12. 12 Epidemiology of COVID-19 Among Children in China [DOI]
  13. 13 Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) [DOI]
  14. 14 Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal [DOI]
  15. 15 Structure, Function, and Evolution of Coronavirus Spike Proteins [DOI]
  16. 16 Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies [DOI]
  17. 17 Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China [DOI]
  18. 18 Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults [DOI]
  19. 19 Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths [DOI]
  20. 20 Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor [DOI]
  21. 21 Coronavirus Disease 2019–COVID-19 [DOI]
  22. 22 Virology, Epidemiology, Pathogenesis, and Control of COVID-19 [DOI]
  23. 23 Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China [DOI]
  24. 24 COVID-19 and smoking: A systematic review of the evidence [DOI]
  25. 25 Discovering drugs to treat coronavirus disease 2019 (COVID-19) [DOI]
  26. 26 Understanding of COVID‐19 based on current evidence [DOI]
  27. 27 Hosts and Sources of Endemic Human Coronaviruses [DOI]
  28. 28 The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis [DOI]
  29. 29 Use of convalescent plasma therapy in SARS patients in Hong Kong [DOI]
  30. 30 Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2 [DOI]
  31. 31 Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV [DOI]
  32. 32 Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection [DOI]
  33. 33 Coronavirus Disease 2019: Coronaviruses and Blood Safety [DOI]
  34. 34 Interspecies transmission and emergence of novel viruses: lessons from bats and birds [DOI]
  35. 35 Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs [DOI]
  36. 36 Drug targets for corona virus: A systematic review [DOI]
  37. 37 Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus [DOI]
  38. 38 Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion [DOI]
  39. 39 Race to find COVID-19 treatments accelerates [DOI]
  40. 40 Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients [DOI]
  41. 41 Novel coronavirus: From discovery to clinical diagnostics [DOI]
  42. 42 [Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures].
  43. 43 Internationally lost COVID-19 cases [DOI]
  44. 44 Anti-SARS coronavirus agents: a patent review (2008 – present) [DOI]
  45. 45 SARS: Epidemiology, Clinical Presentation, Management, and Infection Control Measures [DOI]
  46. 46 A Cured Patient With 2019-nCoV Pneumonia [DOI]
  47. 47 Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation [DOI]
  48. 48 The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells [DOI]
  49. 49 Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) [DOI]
  50. 50 Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China [DOI]
  51. 51 Home visits: a strategy to improve newborn survival - Authors' reply [DOI]
  52. 52 Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)
  53. 53 Saliva: potential diagnostic value and transmission of 2019-nCoV [DOI]
  54. 54 Antiviral treatment of COVID-19 [DOI]
  55. 55 The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms [DOI]
  56. 56 COVID-19, una emergencia de salud pública mundial [DOI]
  57. 57 Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning [DOI]
  58. 58 A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT [DOI]
  59. 59 La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Cited by 23

Prediction of Covid-19 using Machine Learning and Deep Learning approaches: A data driven study

Thanzina Akhter, Labannya Barua, Mahmuda Sultana · 2023 1st International Conference on Circuits, Power and Intelligent Systems (CCPIS) · 2023

Exploration of Factors of Failure to Comply With Home Quarantine During the Outbreak of the COVID-19 Disease in Iran: A Qualitative Study

A. Sharhani, Z. Mohammadi, Kourosh Zarea · MEANDCOVID19 · 2022

Accuracy of COVID-19–Like Illness Diagnoses in Electronic Health Record Data: Retrospective Cohort Study

S. Rao, Catherine H. Bozio, Kristen A. Butterfield · JMIR Formative Research · 2022

The Correlation Between Knowledge and Attitude About Covid-19 with Compliance with the use of Masks at Masombamarket

Nurhidaya Nurhidaya, Nur Afni, Nurjanah Nurjanah · International Journal of Health, Economics, and Social Sciences (IJHESS) · 2021

Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study

E. Tobin, M. Okonofua, A. Adeke · Central African Journal of Public Health · 2021

Covid-19 Disease, Self-Isolation and Physical Inactivity

U. Mehmet, Irez Tulay · 2021

Bibliometric Analysis of Ebola Research Indexed in Web of Science and Scopus (2010-2020)

J. Kawuki, Xiao-Jin Yu, T. Musa · BioMed Research International · 2020

In Silico Evaluation of the Potential Interference of Boceprevir, Calpain Inhibitor II, Calpain Inhibitor XII, and GC376 in the Binding of SARS-CoV-2 Spike Protein to Human Nanobody Nb20

Yuri Alves de Oliveira Só, M. L. Pereira, W. F. Giozza · Open Journal of Biophysics · 2023

INTERNATIONAL YEAR OF MEDICAL AND SOCIAL WORKERS IN UKRAINE: RECOGNITION OF THE ROLE IN THE FIGHT AGAINST THE COVID-19 PANDEMIC AND PROTECTING HEALTH AND WELL-BEING.

N. Ryngach, I. M. Rohach, A. Keretsman · Wiadomosci lekarskie · 2022

Health literacy and preparedness of health workers in the private health sector towards the COVID-19 pandemic: Need for integration into the nationwide response

E. Tobin, V. Ajekweneh, A. Obi · 2021

Showing 17 of 23 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

130

Page views

0

PDF downloads

28

Outbound clicks

23

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.